Nektar Therapeutics (NKTR)

Nektar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.99	44.25	35.28	88.23	25.22	198.96
Short-Term Investments	132.92	210.97	268.34	416.75	708.74	862.94
Cash & Short-Term Investments	175.9	255.23	303.62	504.98	733.96	1,062
Cash Growth	-35.15%	-15.94%	-39.88%	-31.20%	-30.88%	-19.85%
Accounts Receivable	-	-	1.21	5.98	22.49	38.89
Inventory	-	-	16.1	19.2	15.8	15.29
Other Current Assets	10.66	6.07	9.78	15.81	23.33	21.93
Total Current Assets	186.57	261.29	330.7	545.97	795.58	1,138
Net Property, Plant & Equipment	10.57	11.82	36.86	85.89	177.54	186.14
Goodwill	-	-	-	76.5	76.5	76.5
Long-Term Investments	5.37	26.09	25.83	-	64.83	136.66
Other Long-Term Assets	5.02	4.65	4.64	2.25	2.74	1.46
Total Assets	207.53	303.85	398.03	710.6	1,117	1,539
Accounts Payable	14.28	11.56	9.85	12.98	9.75	22.14
Accrued Expenses	35.1	29.97	22.16	36.56	58.01	79.73
Current Portion of Leases	22.01	19.87	19.26	18.67	17.44	13.92
Total Current Liabilities	71.39	61.4	51.27	68.2	85.2	115.78
Long-Term Leases	74.15	82.7	98.52	112.83	125.74	136.37
Other Long-Term Liabilities	86.21	99.02	117.26	162.93	226.75	209.32
Total Long-Term Liabilities	160.35	181.71	215.78	275.76	352.48	345.69
Total Liabilities	231.75	243.11	267.05	343.96	437.68	461.47
Common Stock	0	0	0.02	0.02	0.02	0.02
Treasury Stock	-3	-3	-	-	-	-
Additional Paid-in Capital	3,667	3,660	3,608	3,575	3,517	3,389
Accumulated Other Comprehensive Income	-0.01	0.06	0.08	-6.91	-4.16	-2.3
Retained Earnings	-3,689	-3,596	-3,477	-3,201	-2,833	-2,309
Shareholders' Equity	-24.21	60.74	130.99	366.64	679.51	1,077
Total Liabilities & Equity	207.53	303.85	398.03	710.6	1,117	1,539
Total Debt	96.16	102.56	117.78	131.5	143.18	150.29
Net Cash (Debt)	79.75	152.66	185.84	373.48	590.78	911.61
Net Cash Growth	-47.76%	-17.85%	-50.24%	-36.78%	-35.19%	-0.56%
Net Cash Per Share	5.69	11.13	14.67	29.94	48.35	76.57
Book Value	-24.21	60.74	130.99	366.64	679.51	1,077
Book Value Per Share	-1.73	4.43	10.34	29.39	55.61	90.49
Tangible Book Value	-24.21	60.74	130.99	290.14	603.01	1,001
Tangible Book Value Per Share	-1.73	4.43	10.34	23.26	49.35	84.06

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q